Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Engineered Blood Vessels

Jeffrey Lawson, PhD MD

Blood (2017) 130 (Supplement 1): SCI-12.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-12.SCI-12

Published: 2017

Journal Articles

Moyamoya Disease Predicts Progression of Cerebral Vasculopathy in Patients with Sickle Cell Disease Despite Chronic Transfusion Therapy

Alyssa M Schlenz, PhD, Michael U Antonucci, MD, Rebecca Cafiero, MD, Nina-Serena Burkett, MD, Julie Kanter, MD

Blood (2015) 126 (23): 2071.

https://doi.org/10.1182/blood.V126.23.2071.2071

Published: 2015

Journal Articles

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Alfonso J Tafur, M.D., Edyta Wolny, M.D., Ph.D., Robert McBane, II, M.D., Edyta Sutkowska, Joshua P Slusser, David O Hodge, MS, John A. Heit, Waldemar E Wysokinski, M.D., Ph.D.

Blood (2009) 114 (22): 491.

https://doi.org/10.1182/blood.V114.22.491.491

Published: 2009

Journal Articles

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

Tamas Alexy, MD, PhD, Sony Tucker, MD, Soames Boyle, Leanne Rochanda, Douglas Hood, MD, Vincent L. Rowe, MD, Fred A. Weaver, MD, Howard A. Liebman, MD

Blood (2006) 108 (11): 1491.

https://doi.org/10.1182/blood.V108.11.1491.1491

Published: 2006

Journal Articles

Thrombophilia in Patients with Occlusions of Vascular Bypass Grafts.

Robert Klamroth, MD, Marija Orlovic, Hartmut Rimpler, MD, Helmut Landgraf, MD

Blood (2005) 106 (11): 2156.

https://doi.org/10.1182/blood.V106.11.2156.2156

Published: 2005

Journal Articles

Efficacy of the Direct Thrombin Inhibitor Ximelagatran in Maintaining Small-Diameter Vascular Graft Patency.

Steven P. Schmidt, PhD, Michelle Evancho-Chapman, BS, Amy Deeken, MD, Hans Van Giezen, PhD, Stefan C. Carlsson, MD/PhD

Blood (2005) 106 (11): 1871.

https://doi.org/10.1182/blood.V106.11.1871.1871

Published: 2005

NARROW

Engineered Blood Vessels

Moyamoya Disease Predicts Progression of Cerebral Vasculopathy in Patients with Sickle Cell Disease Despite Chronic Transfusion Therapy

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

Thrombophilia in Patients with Occlusions of Vascular Bypass Grafts.

Efficacy of the Direct Thrombin Inhibitor Ximelagatran in Maintaining Small-Diameter Vascular Graft Patency.

Email alerts

ASH Publications

American Society of Hematology

Engineered Blood Vessels

Moyamoya Disease Predicts Progression of Cerebral Vasculopathy in Patients with Sickle Cell Disease Despite Chronic Transfusion Therapy

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Heparin-PF4 Antibodies Are Frequent after Vascular Surgery, but Not a Frequent Cause of Graft Thrombosis or Thrombocytopenia.

Thrombophilia in Patients with Occlusions of Vascular Bypass Grafts.

Efficacy of the Direct Thrombin Inhibitor Ximelagatran in Maintaining Small-Diameter Vascular Graft Patency.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only